Supernus Pharmaceuticals, Inc.
Clinical trials sponsored by Supernus Pharmaceuticals, Inc., explained in plain language.
-
Huntington's disease drug safety study halted
Disease control TerminatedThis study aimed to check the long-term safety and side effects of an investigational drug called SAGE-718 in people with Huntington's disease. It involved 153 participants who took the drug daily as a capsule. The main goal was to monitor for any health problems, changes in vita…
Phase: PHASE3 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Daily pill tested to shield kids from debilitating migraines
Disease control TerminatedThis study tested whether a daily oral medication called SPN-538 could safely reduce how often children get migraines. It involved kids aged 6 to 11 who had frequent migraines, comparing the drug to a placebo pill. The goal was to see if taking the medicine daily could help contr…
Phase: PHASE4 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC